We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Study Details Interaction between Galectin-1 and Carbohydrate Ligands

By LabMedica International staff writers
Posted on 23 Aug 2017
Print article
Image: In this model, the complex sugar molecule (colored) attaches to the tumor protein galectin-1, which is shown in black and white (Photo courtesy of Workgroup Seibel, VCH-Wiley).
Image: In this model, the complex sugar molecule (colored) attaches to the tumor protein galectin-1, which is shown in black and white (Photo courtesy of Workgroup Seibel, VCH-Wiley).
A team of German researchers used advanced X-ray crystallography techniques to develop a structural understanding of the interaction between the galectin-1 protein and its carbohydrate ligands.

The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. Galectins are defined by their binding specificity for beta-galactoside sugars, such as N-acetyllactosamine (Galbeta1-3GlcNAc or Galbeta1-4GlcNAc), which can be bound to proteins by either N-linked or O-linked glycosylation. Unlike the majority of lectins they are not membrane bound, but soluble proteins with both intra- and extracellular functions. They have distinct but overlapping distributions but are found primarily in the cytosol, nucleus, extracellular matrix, or in circulation. Galectin-1 may act as an autocrine negative growth factor that regulates cell proliferation. Expression of galectin-1in Hodgkin lymphoma has been shown to mediate immunosuppression of CD8+ T-cells.

In order to study the interaction between galectin-1 and its ligands, investigators at the University of Wurzburg (Germany) prepared a multifunctional natural scaffold based on N-acetyllactosamine (LacNAc). It served as an anchor motif for further expansion by the Sharpless–Huisgen–Meldal reaction, which resulted in ligands with a binding mode almost identical to that of the natural carbohydrate template. X-ray crystallography was then used to provide a structural understanding of the galectin-1–ligand interactions.

"We have equipped the sugar molecule with a docking site, for example, to connect it with a fluorescent dye or a drug," said senior author Dr. Jürgen Seibel, professor of organic chemistry at the University of Wurzburg. "Among other things, it is known that galectin-1 hides the tumor cells from the immune system. When galectin-1 is blocked, the immune system can recognize the tumor and attack it with T cells."

Results of the X-ray crystallography study were published in the August 4, 2017, issue of the journal ChemBioChem.

Related Links:
University of Wurzburg

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Ultrasound-based duplex sonography combined with a new genetic testing procedure can identify clonal haematopoiesis (Photo courtesy of 123RF)

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk

A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.